These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26821359)

  • 1. Patient, Caregiver, and Nurse Preferences for Treatments for Bone Metastases from Solid Tumors.
    Qian Y; Arellano J; Hauber AB; Mohamed AF; Gonzalez JM; Hechmati G; Gatta F; Harrelson S; Campbell-Baird C
    Patient; 2016 Aug; 9(4):323-33. PubMed ID: 26821359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicians' preferences for bone metastases treatments in France, Germany and the United Kingdom.
    Qian Y; Arellano J; Gatta F; Hechmati G; Hauber AB; Mohamed AF; Bahl A; von Moos R; Body JJ
    BMC Health Serv Res; 2018 Jul; 18(1):518. PubMed ID: 29970078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicians' preferences for bone metastases drug therapy in the United States.
    Arellano J; Hauber AB; Mohamed AF; Gonzalez JM; Collins H; Hechmati G; Gatta F; Qian Y
    Value Health; 2015 Jan; 18(1):78-83. PubMed ID: 25595237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physician preferences for bone metastasis drug therapy in Canada.
    Arellano J; González JM; Qian Y; Habib M; Mohamed AF; Gatta F; Hauber AB; Posner J; Califaretti N; Chow E
    Curr Oncol; 2015 Oct; 22(5):e342-8. PubMed ID: 26628874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients' preferences for bone metastases treatments in France, Germany and the United Kingdom.
    Hechmati G; Hauber AB; Arellano J; Mohamed AF; Qian Y; Gatta F; Haynes I; Bahl A; von Moos R; Body JJ
    Support Care Cancer; 2015 Jan; 23(1):21-8. PubMed ID: 24939674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient and parent preferences for immunoglobulin treatments: a conjoint analysis.
    Mohamed AF; Kilambi V; Luo MP; Iyer RG; Li-McLeod JM
    J Med Econ; 2012; 15(6):1183-91. PubMed ID: 22846048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient Preferences for Preventive Migraine Treatments: A Discrete-Choice Experiment.
    Mansfield C; Gebben DJ; Sutphin J; Tepper SJ; Schwedt TJ; Sapra S; Shah N
    Headache; 2019 May; 59(5):715-726. PubMed ID: 30861110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantifying benefit-risk preferences for new medicines in rare disease patients and caregivers.
    Morel T; Aymé S; Cassiman D; Simoens S; Morgan M; Vandebroek M
    Orphanet J Rare Dis; 2016 May; 11(1):70. PubMed ID: 27225337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing the Relative Importance of Attributes of Metastatic Renal Cell Carcinoma Treatments to Patients and Physicians in the United States: A Discrete-Choice Experiment.
    González JM; Doan J; Gebben DJ; Boeri M; Fishman M
    Pharmacoeconomics; 2018 Aug; 36(8):973-986. PubMed ID: 29869777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alignment of preferences in the treatment of multiple myeloma - a discrete choice experiment of patient, carer, physician, and nurse preferences.
    Fifer SJ; Ho KA; Lybrand S; Axford LJ; Roach S
    BMC Cancer; 2020 Jun; 20(1):546. PubMed ID: 32527324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient preferences for treatments to delay bone metastases.
    Hauber AB; Arellano J; Qian Y; González JM; Posner JD; Mohamed AF; Gatta F; Tombal B; Body JJ
    Prostate; 2014 Nov; 74(15):1488-97. PubMed ID: 25132622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient preferences for osteoporosis in Spain: a discrete choice experiment.
    Darbà J; Restovic G; Kaskens L; Balbona MA; Carbonell A; Cavero P; Jordana M; Prieto C; Molina A; Padró I
    Osteoporos Int; 2011 Jun; 22(6):1947-54. PubMed ID: 20838770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient Preferences for Injectable Treatments for Multiple Sclerosis in the United States: A Discrete-Choice Experiment.
    Poulos C; Kinter E; Yang JC; Bridges JF; Posner J; Reder AT
    Patient; 2016 Apr; 9(2):171-80. PubMed ID: 26259849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A community-engaged approach to quantifying caregiver preferences for the benefits and risks of emerging therapies for Duchenne muscular dystrophy.
    Peay HL; Hollin I; Fischer R; Bridges JF
    Clin Ther; 2014 May; 36(5):624-37. PubMed ID: 24852596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient and caregiver preferences for haemophilia A treatments: A discrete choice experiment.
    Su J; Li N; Joshi N; Ng X; Botteman M; Shah R; Jain N; Lyn N; Preblick R
    Haemophilia; 2020 Nov; 26(6):e291-e299. PubMed ID: 32937681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient and caregiver preferences for haemophilia treatments: A discrete-choice experiment.
    Garcia VC; Mansfield C; Pierce A; Leach C; Smith JC; Afonso M
    Haemophilia; 2024 Mar; 30(2):375-387. PubMed ID: 38198352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PREFERENCES OF PATIENTS WITH MULTIPLE SCLEROSIS FOR ATTRIBUTES OF INJECTABLE MULTIPLE SCLEROSIS TREATMENTS IN THE UNITED KINGDOM AND FRANCE.
    Poulos C; Kinter E; van Beek J; Christensen K; Posner J
    Int J Technol Assess Health Care; 2018 Jan; 34(4):425-433. PubMed ID: 30251947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferences of patients, their family caregivers and vascular surgeons in the choice of abdominal aortic aneurysms treatment options: the PREFER study.
    Faggioli G; Scalone L; Mantovani LG; Borghetti F; Stella A;
    Eur J Vasc Endovasc Surg; 2011 Jul; 42(1):26-34. PubMed ID: 21334928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Societal preferences for rheumatoid arthritis treatments: evidence from a discrete choice experiment.
    Harrison M; Marra C; Shojania K; Bansback N
    Rheumatology (Oxford); 2015 Oct; 54(10):1816-25. PubMed ID: 25989956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient and caregiver benefit-risk preferences for nonmetastatic castration-resistant prostate cancer treatment.
    Srinivas S; Mohamed AF; Appukkuttan S; Botteman M; Ng X; Joshi N; Tsai JH; Fang J; Waldeck AR; Simmons SJ
    Cancer Med; 2020 Sep; 9(18):6586-6596. PubMed ID: 32725755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.